BrightSpring (BTSG) officer gets equity grants, sells shares
Rhea-AI Filing Summary
BrightSpring Health Services director and officer Jon B. Rousseau reported a mix of equity grants, option activity, and share sales. On March 4, 2026, he exercised 220,000 stock options at $6.37 per share and sold 220,000 common shares at $41.15 per share in a registered public offering.
On March 4–5, 2026, he was awarded several blocks of stock options and restricted stock units (RSUs), including 458,008 options, 955,823 options, and 186,845 RSUs. Some options are fully vested, while others and the RSUs vest in twelve equal quarterly installments starting April 25, 2026. After these transactions, he directly owned about 1,023,880 common shares, plus additional option and share interests held indirectly through family trusts, for which he disclaims beneficial ownership beyond his economic interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) | 458,008 | $0.00 | -- |
| Grant/Award | Common Stock | 186,845 | $0.00 | -- |
| Grant/Award | Stock Options (Right to Buy) | 955,823 | $0.00 | -- |
| Exercise | Stock Options (Right to Buy) | 220,000 | $0.00 | -- |
| Exercise | Common Stock | 220,000 | $6.37 | $1.40M |
| Sale | Common Stock | 220,000 | $41.15 | $9.05M |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on March 4, 2026, at a price of $41.15, before deducting underwriting discounts and commissions. On March 5, 2026, the Reporting Person was granted restricted stock units ("RSUs") which vest in twelve equal quarterly installments commencing on April 25, 2026. Each RSU represents a contingent right to receive one share of common stock upon settlement. The Reporting Person states that this filing shall not be an admission that the Reporting Person is the beneficial owner of any of the securities reported herein as indirectly owned, and the Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest therein. No new stock options have been awarded. The transaction reported herein reflects vesting of performance-based stock options ("Performance Options") previously awarded to the Reporting Person on October 16, 2019, vesting subject to performance conditions that were subsequently satisfied on March 3, 2026. The Performance Options are fully vested. These options are fully vested. Options vest in twelve equal quarterly installments commencing on April 25, 2026.